AML cell lines exhibited a wider expression of inhibitory molecules, including CD155, Gal-9 and HLA-E (30–100%, 80–100% and 60–80%, respectively, Figure 1c). The gene discussed is LGALS9; the disease is acute myeloid leukemia.